ArticleAdvances in hematology2025

SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis (EDKA) in Hematologic Malignancy Patients: A Case Series.

Andrew Artz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.